AM
Amrutanjan Health Care Ltd (AMRUTANJAN)
₹521.45
Mkt cap
₹1,428 Cr
P/E ratio
23.00
P/B
4.07
Div yield
0.99%
ROE
18.40%
ROCE
24.80%
EPS (TTM)
₹22.67
Book value
₹128
52W range
477–760
Sector
Healthcare
Price history
Previous close
AHCL has been manufacturing ayurvedic balm for pain management since 1893, and is currently managed by the third-generation of promoters. The company is more than 120 years old and is into OTC products in the segments of pain management, women's hygiene, and packaged fruit juice drink. [1]
NSE AMRUTANJANBSE 590006
Health check
Constructive
ValuationCheap
ProfitabilityStrong
GrowthModerate
TechnicalsBearish
52-week range
−31.40% from high₹521
₹477+9.43% from low₹760
Current
₹521.45
Prev close
₹519.00
Day
+0.47%
Price performance
1D
+0.47%
1W
+2.94%
1M
+2.78%
3M
−3.09%
6M
+2.11%
1Y
−28.11%
YTD
−22.49%
Financials
Revenue, profit & margin
P/E ratio
23.0×
AMRUTANJAN is 33% below the sector median of 34.6×
AMRUTANJAN23.0×
Sector median34.6×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 77.86 | 99.31 | 116.99 | 127.06 | 83.74 | 109.92 | 122.75 | 135.41 | 94.05 | 117.70 | 141.04 | 149.77 | 102.97 | |
| Expenses | 70.71 | 92.47 | 95.42 | 110.82 | 80.19 | 96.32 | 99.40 | 117.71 | 85.61 | 101.18 | 115.87 | 124.22 | 96.73 | |
| Operating Profit | 7.15 | 6.84 | 21.57 | 16.24 | 3.55 | 13.60 | 23.35 | 17.70 | 8.44 | 16.52 | 25.17 | 25.55 | 6.24 | |
| OPM % | 9.18% | 6.89% | 18.44% | 12.78% | 4.24% | 12.37% | 19.02% | 13.07% | 8.97% | 14.04% | 17.85% | 17.06% | 6.06% | |
| Other Income | 3.69 | 3.95 | 3.76 | 4.95 | 4.45 | 4.05 | 4.36 | 4.82 | 4.43 | 4.30 | 2.87 | -2.88 | 1.78 | |
| Interest | 0.02 | 0.03 | 0.05 | 0.05 | 0.06 | 0.06 | 0.06 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | |
| Depreciation | 1.39 | 1.55 | 1.58 | 1.53 | 1.59 | 1.65 | 1.66 | 1.62 | 1.53 | 1.56 | 1.62 | 1.61 | 1.92 | |
| Profit before tax | 9.43 | 9.21 | 23.70 | 19.61 | 6.35 | 15.94 | 25.99 | 20.86 | 11.29 | 19.21 | 26.37 | 21.01 | 6.06 | |
| Tax % | 25.56% | 25.62% | 26.41% | 30.34% | 27.24% | 25.97% | 25.93% | 27.23% | 26.40% | 27.33% | 26.20% | 22.94% | 28.05% | |
| Net Profit | 7.01 | 6.85 | 17.45 | 13.66 | 4.62 | 11.80 | 19.25 | 15.18 | 8.31 | 13.96 | 19.45 | 16.19 | 4.37 | |
| EPS in Rs | 2.40 | 2.37 | 6.04 | 4.72 | 1.60 | 4.08 | 6.66 | 5.25 | 2.87 | 4.83 | 6.73 | 5.60 | 1.51 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −8.51% · closed higher next day 0 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 11 Aug '26◦ |
| Earnings day | −8.51% |
| +1 day | −7.90% |
| +5 days | −6.55% |
| +15 days | −6.28% |
| +30 days | −4.41% |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Results analysis
Shareholding
as of Jun 202646.52%Promoter
Promoters46.52%
FIIs2.44%0.27
DIIs12.29%0.37
Public38.72%0.11
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | ₹1,837.30 | 34.90 | 4,40,830 | 0.87% | 2,901 | +5.95% | 15,300 | +10.46% | 20.53% |
| Divi's Lab. | ₹9,375.00 | 83.54 | 2,48,877 | 0.32% | 902 | +65.50% | 3,080 | +27.80% | 21.97% |
| Torrent Pharma. | ₹4,840.00 | 82.51 | 1,84,098 | 0.79% | 566 | +5.79% | 4,921 | +54.85% | 15.19% |
| Zydus Lifesci. | ₹1,160.00 | 23.77 | 1,15,710 | 0.09% | 990 | −35.09% | 8,017 | +21.96% | 21.14% |
| Cipla | ₹1,394.50 | 31.48 | 1,12,656 | 0.93% | 786 | −39.19% | 7,119 | +2.33% | 15.49% |
| Laurus Labs | ₹1,954.00 | 96.56 | 1,05,577 | 0.10% | 362 | +125.49% | 2,026 | +29.10% | 17.76% |
| Aurobindo Pharma | ₹1,734.00 | 26.39 | 99,771 | 0.23% | 1,032 | +28.11% | 9,150 | +16.30% | 12.86% |
| Amrutanjan Healt | ₹493.80 | 22.95 | 1,428 | 0.99% | 4 | −29.84% | 103 | +9.48% | 24.84% |
| Median: 158 Co. | ₹433.90 | 34.56 | 2,205 | 0.08% | 13 | +29.57% | 164 | +18.57% | 14.96% |
Filings
Annual reports15
Concall transcripts32
Credit ratings6
Announcements5
Business Responsibility and Sustainability Reporting (BRSR) 28 Aug - Amrutanjan filed FY26 BRSR and AGM notice; final dividend ₹2.90/share, record date Sept. 11, 2026.Reg. 34 (1) Annual Report. 28 Aug - Submitted FY2025-26 annual report; 89th AGM on 23 Sept 2026; final dividend ₹2.90 per share.Investor Presentation For The Quarter Ended 30Th June 2026 12 AugRecord Date For The Final Dividend And AGM 11 Aug - 11 September 2026 record date fixed for FY26 final dividend.Board Meeting Outcome for Financial Results And Outcome Of The Board Meeting 11 Aug - Q1 FY27 results approved; PAT Rs 436.57 lakh. AGM on 23 Sep 2026; record date 11 Sep.